The cellular neurobiology of depression
The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Abstract
Major depressive disorders, long considered to be of neurochemical origin, have recently been associated with impairments in signaling pathways that regulate neuroplasticity and cell survival. Agents designed to directly target molecules in these pathways may hold promise as new therapeutics for depression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Antidepressant therapies may compensate for this dysfunction by modulating the pathological limbic activity that putatively mediates depressive symptoms (Drevets et al, 2002a), or by enhancing the expression of neurotrophic factors that protect medial network function from the effects of repeated stress (Manji et al, 2001).”
From Neurocircuitry of Mood Disorders (2010) · cites this paper as Manji et al, 2001
In the citing paper
“Somatic antidepressant therapies may compensate for this dysfunction by modulating the pathological limbic activity which putatively mediates depressive symptoms (Drevets et al. 2002a) and the expression of neurotrophic/neuroprotective factors that preserve the function of the MPFC (Manji et al. 2001).”
From Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression (2008) · cites this paper as Manji et al. 2001
In the citing paper
“Depression is often associated with elevated HPA axis activity and increased levels of glucocorticoids, as well as disruption of negative feedback mechanisms21–23.”
From Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants (2016) · cites this paper as [22]
Citations
Cites
Neurogenesis in the adult human hippocampus
Eriksson, P. S., Perfilieva, E., Björk-Eriksson, T., Alborn, A.-M., Nordborg, C., Peterson, D. A., & Gage, F. H. (1998) · Nature Medicine · doi:10.1038/3305 · Cited by 6,369 · cited 1×
“However, the demonstration that neurogenesis occurs in the adult human brain into senescenc”
BackgroundThe Bcl-2 Protein Family: Arbiters of Cell Survival
Adams, J. M., & Cory, S. (1998) · Science · doi:10.1126/science.281.5381.1322 · Cited by 5,332 · cited 1×
“Modest changes in this signaling cascade or in the levels of the Bcl-2 family of proteins (potentially due to genetic, illness or insult-related factors) could therefore profoundly affect cellular viabilit”
BackgroundGlobal mortality, disability, and the contribution of risk factors: Global Burden of Disease Study
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07495-8 · Cited by 4,492 · cited 1×
“It is thus not altogether surprising that the Global Burden of Disease Study has identified MDDs among the leading causes of disability worldwide, and as illnesses likely to represent an increasingly greater health, societal and economic problem in the coming year”
BackgroundAntidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856 · cited 1×
“Current research is examining the potential efficacy of antagonists of corticotropin-releasing factor (CRF), antiglucocorticoids and direct and indirect glutamate antagonist”
BackgroundSelf-citationChronic antidepressant treatment increases neurogenesis in adult rat hippocampus
Malberg, J. E., Eisch, A. J., Nestler, E. J., & Duman, R. S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09104.2000 · Cited by 3,111 · cited 1×
“These studies demonstrate that chronic administration of different classes of antidepressants increases the proliferation and survival of new neuron”
BackgroundPsychopharmacology: The Fourth Generation of Progress
Bloom, F. E., & Kupfer, D. J. (1995) · Medical Entomology and Zoology · Cited by 2,985
A molecular mechanism for the effect of lithium on development.
Klein, P. S., & Melton, D. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8455 · Cited by 2,301 · cited 1×
“Moreover, lithium also inhibits the activity of glycogen synthase kinase 3β (GSK-3β”
BackgroundThe Corticosteroid Receptor Hypothesis of Depression
Holsboer, F. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00159-7 · Cited by 2,181
A molecular and cellular theory of depression
Duman, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830190015002 · Cited by 2,129 · cited 1×
“have demonstrated that an important pathway involved in cell survival and plasticity, the cAMP–CREB cascade, is up-regulated by antidepressant treatmen”
BackgroundTHE EFFECTS OF STRESSFUL LIFE EVENTS ON DEPRESSION
Kessler, R. C. (1997) · Annual Review of Psychology · doi:10.1146/annurev.psych.48.1.191 · Cited by 2,111 · cited 1×
“Thus, although MDDs undoubtedly have a strong genetic basis, severe stressors have been associated with a substantial increase in risk for the onset of MDDs in susceptible individuals ( Table 3”
Background
Research works printed but not linked: 4
- Garlow, S.J., Musselman, D.L. & Nemeroff C.B. The Neurochemistry of Mood Disorders clinical studies. in Neurobiology of Mental Illness. (eds. Charney, D.S., Nester, E.J. & Bunney, B.S.) 348–364 (Oxford Press, New York, 1999).
- Drevets, W.C., Gadde, K. & Krishnan, R. Neuroimaging studies of depression. in Neurobiology of Mental Illness. (eds. Charney, D.S., Nester, E.J. & Bunney, B.S.) 394–418 (Oxford Press, New York, 1999).
- LeDoux, J.E. Emotion. in Handbook of Physiology—The Nervous System, Vol. V. (eds. Mills, J., Mountcastle, V.B., Plum, F. & Geiger, S.R.) 373–417 (Williams & Wilkins, Baltimore, 1987).
- Manji, H.K. et al. Regulation of signal transduction pathways by mood stabilizing agents: Implications for the pathophysiology and treatment of bipolar affective disorder. in Bipolar Medications: Mechanisms of Action. (eds. Manji, H.K., Bowden, C.L. & Belmaker, R.H.) 129–177 (American Psychiatric Press, Washington, DC, 2000).
Cited by
Items 801–900 of 1,000
Tokarski, K., Bobula, B., Grzegorzewska-Hiczwa, M., Kusek, M., & Hess, G. (2012) · Pharmacological Reports · doi:10.1016/s1734-1140(12)70928-3 · Cited by 10
“The abnormalities in cognitive functions and emotional behavior occurring during depressive disorders implicate the involvement of the frontal cortex in the pathophysiology of depression and in the action of antidepressant drugs [44, 45, 55].”
BackgroundChu, X. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.11.044 · Cited by 10
“This theory is consistent with the fact that decreased CSF monoamine neurotransmitters and their metabolites are observed in depressed patients [19].”
Sartori, S. B., Burnet, P. W. J., Sharp, T., & Singewald, N. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.02.013 · Cited by 10
A common role for psychotropic medications: memory impairment
Parra, A. (2002) · Medical Hypotheses · doi:10.1016/s0306-9877(02)00350-x · Cited by 12
Tsiouris, J. A., Chauhan, V. P. S., Sheikh, A. M., Chauhan, A., Malik, M. N., & Vaughan, M. R. (2004) · Canadian Journal of Zoology · doi:10.1139/z04-122 · Cited by 10
“Further, metabolic depression could explain the mostly state-dependent abnormal neurobiological findings in major depression, for which there is, as yet, no clear explanation (Manji et al. 2001; Nestler et al. 2002).”
BackgroundAboukhatwa, M. A., & Undieh, A. S. (2010) · BMC Neuroscience · doi:10.1186/1471-2202-11-10 · Cited by 10
“However, such postsynaptic actions have not been fully elucidated, although various tertiary signaling effects ranging from alterations of ion channel activity to modulation of protein kinases and gene transcription have been proposed [17,20-22].”
BackgroundDepression: The Brain Finally Gets Into the Act
Jacobs, B. L. (2004) · Current Directions in Psychological Science · doi:10.1111/j.0963-7214.2004.00284.x · Cited by 13
Kobayashi, Y., & Segi‐Nishida, E. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.172767 · Cited by 13
Deep transcranial magnetic stimulation using figure-of-eight and Halo coils
Lu, M., & Ueno, S. (2015) · IEEE International Magnetics Conference · doi:10.1109/intmag.2015.7156713 · Cited by 10
Lithium protection from glutamate excitotoxicity: therapeutic implications
Chuang, D. (2004) · Clinical Neuroscience Research · doi:10.1016/j.cnr.2004.09.016 · Cited by 10
Épisode dépressif majeur : dix ans d’expérience thérapeutique avec la fluoxétine
Gourion, D., Perrin, E., & Quintin, P. (2004) · L Encéphale · doi:10.1016/s0013-7006(04)95453-x · Cited by 15
Pei, Q., Sprakes, M., Millan, M. J., Rochat, C., & Sharp, T. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.03.002 · Cited by 10
Marcadores Biológicos da Depressão:
Perito, M. E. S., & Fortunato, J. J. (2001) · Revista Neurociências · doi:10.34024/rnc.2012.v20.8235 · Cited by 13
Antidepressant effects of acupuncture in a murine model: regulation of neurotrophic factors
Yamamoto, T., Kawanokuchi, J., Nagaoka, N., Takagi, K., Ishida, T., Hayashi, T., & Ma, N. (2022) · Acupuncture in Medicine · doi:10.1177/09645284221085279 · Cited by 11
Shalaby, A. M., & Kamal, S. M. (2012) · PubMed Central · doi:10.4103/0976-500x.95509 · Cited by 9
“[1] In particular, cyclic adenosine monophosphate (cAMP) - mediated signalling appears to have a key role in the pathophysiology and pharmacotherapy of depression.”
BackgroundPałucha-Poniewiera, A. (2022) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2022.173454 · Cited by 10
“targets, receptors, synapses and the entire neuronal network (Castrén, 2005; Manji et al., 2001; Taylor et al., 2005).”
BackgroundHypothesized mechanisms and sites of action of electroconvulsive therapy
Michael, N. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511576393.005 · Cited by 11
The biology of post-traumatic stress disorder
Turnbull, G. J. (2006) · Psychiatry · doi:10.1053/j.mppsy.2006.04.001 · Cited by 11
Picchini, A. M., Manji, H. K., & Gould, T. D. (2004) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2004.11.020 · Cited by 11
Self-citationLucki, A., Klein, E., Karry, R., & Ben‐Shachar, D. (2013) · Journal of Neural Transmission · doi:10.1007/s00702-013-1099-5 · Cited by 9
Expression analysis for inverted effects of serotonin transporter inactivation
Ichikawa, M., Okamura-Oho, Y., Shimokawa, K., Kondo, S., Nakamura, S., Yokota, H., Himeno, R., Lesch, K., & Hayashizaki, Y. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.01.041 · Cited by 9
Maiwulanjiang, M., Zhu, K. Y., Chen, J., Miernisha, A., Xu, S. L., Du, C. Y. Q., Lau, K. K. M., Choi, R. C. Y., Dong, T. T.-X., Aisa, H. A., et al. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/687958 · Cited by 9
“Neuronal cell death was found in depressed brain [28, 29].”
BackgroundCarlberg, L., Schosser, A., Calati, R., Serretti, A., Massat, I., Papageorgiou, K., Kocabaş, N. A., Mendlewicz, J., Zohar, J., Montgomery, S., et al. (2014) · International Journal of Neuroscience · doi:10.3109/00207454.2014.936554 · Cited by 9
Mortality and Poststroke Depression
Dean, C. E. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.8.1506 · Cited by 9
Different Mechanisms Between Melancholic and Atypical Depression
Lee, H., & Kim, Y. (2015) · InTech eBooks · doi:10.5772/59959 · Cited by 13
Changes in signaling pathways regulating neuroplasticity induced by neurokinin 1 receptor knockout
Musazzi, L., Pérez, J., Hunt, S. P., Racagni, G., & Popoli, M. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.03949.x · Cited by 10
“Recent findings demonstrated the role of postreceptor signaling cascades and mechanisms regulating neuronal plasticity in mood disorders (Duman et al., 1999; Manji et al., 2001; Popoli et al., 2001).”
BackgroundInput-output relation of midbrain connectomics in a rodent model of depression
Tong, Y., Cho, S. G., Coenen, V. A., & Döbrössy, M. D. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.10.124 · Cited by 8
Lu, M., & Ueno, S. (2013) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc.2013.6609620 · Cited by 8
“Although TMS treatment for depression with a common target in the dorsolateral prefrontal cortex has improved over the last years [5], current TMS methodologies do not yet yield the desired results, especially for major depressive disorder which is a highly prevalent and disabling condition associated with significant…”
BackgroundThe Cytokines and Depression Hypothesis: An Evaluation
Dunn, A. J. (2008) · Neuroimmune biology · doi:10.1016/s1567-7443(07)10023-5 · Cited by 10
Zubenko, G. S., & Hughes, H. B. (2010) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31133 · Cited by 8
“studies of temporal cortex from patients with MDD, in the hippocampus and nucleus accumbens of animal models of MDD and related disorders, and in the brains of rodents exposed to chronic treatment with antidepressant drugs [Manji et al., 2001; Nestler et al., 2002; Carlezon et al., 2005].”
BackgroundInfluentialBiological Models of Unipolar Depression
Cleare, A. J. (2004) · Wiley eBooks · doi:10.1002/9780470696385.ch2 · Cited by 9
Resveratrol: More than a phytochemical
Hassanzadeh, P., Atyabi, F., & Dinarvand, R. (2015) · Biomedical Reviews · doi:10.14748/bmr.v26.1540 · Cited by 7
Antidepressant-Like Effect of Rosmarinus officinalis Extract in Male Mice
Mukhtar, E. J. A., Selman, S. M., Sahib, Z. H., & Naji, H. (2013) · Medical Journal of Babylon · Cited by 8
Original experimental rat model of blast-induced mild traumatic brain injury: a pilot study
Matsuura, H., Ohnishi, M., Yoshioka, Y., Togami, Y., Hosomi, S., Umemura, Y., Ebihara, T., Shimizu, K., Ogura, H., & Shimazu, T. (2021) · Brain Injury · doi:10.1080/02699052.2020.1861653 · Cited by 8
“The behavioral abnormalities occurring in the blast group may be related to the MRI and immunohistochemical findings because dysfunction caused by neuronal damage in the hippocampus presents as a pathophysiology of depression (18).”
BackgroundAnandan, R., Kannan, V., Sudalaimani, D. K., Janani, P. R., & Athiappan, M. (2023) · Environmental Progress & Sustainable Energy · doi:10.1002/ep.14213 · Cited by 7
“13 The most prevalent symptom of mental illness is mood fluctuation.”
BackgroundRoczniak, W., Babuśka-Roczniak, M., Kwapuliński, J., Brodziak-Dopierała, B., Widuchowski, W., Cipora, E., Nowak, P., & Oświęcimska, J. (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2014.08.018 · Cited by 7
“Agonists of the 5-HT3 receptor enhance the release of endogenous 5-HT and CCK, but inhibit the secretion of endogenous NA and acetylcholine in the cerebral cortex [10,11].”
BackgroundŻurawek, D., Faron‐Górecka, A., Kuśmider, M., Solich, J., Kolasa, M., Szafran‐Pilch, K., Kmiotek‐Wasylewska, K., Gruca, P., Papp, M., & Dziedzicka‐Wasylewska, M. (2014) · Neuromethods · doi:10.1007/978-1-4939-2196-6_20 · Cited by 7
Li, C., Xu, X., Zhang, X., Cheng, K., Guo, Y., Jie, J., Guo, H., He, Y., Zhou, C., Gui, S., et al. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s176399 · Cited by 7
“In addition, the ERK/CREB/BDNF pathway also participated in the pathophysiology of major depressive disorder.(25) Based on this, in this study we aimed to investigate the relationship between BDV and ERK/CREB/BDNF pathway.”
BackgroundMalik, A. S., & Mumtaz, W. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-817420-3.00004-7 · Cited by 7
Onasanwo, S. A., Faborode, O. S., & Ilenre, K. O. (2016) · Nigerian Journal of Physiological Sciences · Cited by 8
Approche neurobiologique de la dépression : nouvelles données
Lanfumey, L., & Hamon, M. (2005) · Therapies · doi:10.2515/therapie:2005064 · Cited by 10
Epilepsy and Depression: Imaging Potential Common Factors
Theodore, W. H. (2004) · Clinical EEG and Neuroscience · doi:10.1177/155005940403500110 · Cited by 7
Neuroimmune Mediators: Are Cytokines Mediators of Depression?
de Beaurepaire, R., Swiergiel, A. H., & Dunn, A. J. (2005) · Wiley eBooks · doi:10.1002/9783527619672.ch22 · Cited by 8
Bee, R., Ahmad, M., & Verma, S. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527321666220516105907 · Cited by 7
Physical Exercise Restores the Generation of Newborn Neurons in an Animal Model of Chronic Epilepsy
Mendonça, F. N., Santos, L. E. C., Rodrigues, A. M., da Silva, S. G., Arida, R. M., da Silveira, G. A., Scorza, F. A., & de Almeida, A.-C. G. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00098 · Cited by 6
“Disruption of the neurogenesis induced by antidepressant drugs blocks the behavioral improvements due to these drugs (Malberg et al., 2000; Manji et al., 2001; Nestler et al., 2002; Santarelli et al., 2003; Drew and Hen, 2007; Sahay and Hen, 2007; David et al., 2009).”
BackgroundDoes neurogenesis relate to depression and do antidepressants affect neurogenesis?
Krzak, A. M., Cao, J. J. L., Agius, M., & Höschl, C. (2017) · PubMed · Cited by 8
Repeated blockade of 5-HT₇ receptors depresses glutamatergic transmission in the rat frontal cortex.
Tokarski, K., Kusek, M., & Hess, G. (2012) · PubMed · Cited by 7
Antidepressant-like Potential of Sida tiagii Bhandari Fruits in Mice
Datusalia, A. K., Sharma, S., Kalra, P., & Samal, M. K. (2009) · Eisei kagaku · doi:10.1248/jhs.55.641 · Cited by 6
Serotonergic Modulation of Cognition in Prefrontal Cortical Circuits in Major Depression
Ramírez-Mahaluf, J. P., & Compte, A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809825-7.00002-x · Cited by 7
Dhingra, D., & Deepak, D. (2019) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2019.v12i1.28981 · Cited by 6
“Depression occurs mainly due to monoaminergic neurotransmitter imbalances (such as serotonin, norepinephrine, and dopamine) [3], oxidative and nitrosative stress [4].”
BackgroundAnkolekar, S. M., & Sikdar, S. K. (2015) · Journal of Biosciences · doi:10.1007/s12038-015-9527-3 · Cited by 6
“Lithium brings about adult neurogenesis in hippocampus and this is thought to be one of the reasons for its effectiveness in prophylaxis (Chen et al. 2000; Manji et al. 2001).”
BackgroundAykaç, A., Gören, M. Z., & Cabadak, H. (2015) · Turkish Journal of Biochemistry · doi:10.5505/tjb.2015.50479 · Cited by 6
Envisioning the crosstalk between environmental enrichment and epilepsy: A novel perspective
Akyüz, E., & Eroğlu, E. (2020) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2020.107660 · Cited by 8
Drevets, W. C., & Furey, M. L. (2009) · Elsevier eBooks · doi:10.1016/b978-008045046-9.00846-9 · Cited by 10
Self-citationProspective and retrospective memory in normal and pathological aging
Livner, Å. (2009) · Figshare · Cited by 11
Zannikos, P., Solanki, B., Meulder, M. D., Badorrek, P., Hohlfeld, J. M., & Singh, J. B. (2023) · Clinical Pharmacokinetics · doi:10.1007/s40262-023-01273-z · Cited by 5
Bansal, S., & Dhingra, D. (2023) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2023.00589 · Cited by 5
Choi, S.-O., Choi, J.-G., & Yun, J.-Y. (2023) · Brain Sciences · doi:10.3390/brainsci13081157 · Cited by 7
Mitsi, V., Ruiz, A., Polizu, C., Farzinpour, Z., Ramakrishnan, A., Serafini, R. A., Parise, E. M., Floodstrand, M., Sial, O. K., Gaspari, S., et al. (2024) · Molecular Pharmacology · doi:10.1124/molpharm.123.000753 · Cited by 6
Wu, Y., Cai, J., Liu, H., Li, C., Tang, Q., & Zhang, Y. (2024) · Pharmaceuticals · doi:10.3390/ph17121637 · Cited by 7
“Despite great efforts to pursue the effective treatment of depression, the current medications represented by the selective serotonin reuptake inhibitors (SSRIs) are insufficient and have many shortcomings, such as slow onset, low efficacy, and serious adverse effects [3–5].”
The Interacting Neuroendocrine Network in Stress-Inducing Mood Disorders
Leff, P., Hernández, M. E., Becerril‐Villanueva, E., Martinez, C. B. D. R., Téllez-Santillán, C., Pérez-Tapia, M., Salazar, A., Antón, B., Berlanga, C., & Pavón, L. (2010) · The Open Neuroendocrinology Journal · doi:10.2174/1876528901003010180 · Cited by 6
“However, pharmacological studies showed that the expression and function of the molecules involved in the NMDA-receptor signaling pathway are significantly upregulated upon antidepressant treatment [22,26-28].”
BackgroundCellular Plasticity and the Pathophysiology of Depression
Jay, T. M. (2011) · doi:10.1007/978-1-908517-18-0_4 · Cited by 5
Bases biochimiques et neurobiologiques de la psychiatrie
de Beaurepaire, R. (2004) · Encyclopédie médico-chirurgicale. Psychiatrie · doi:10.1016/j.emcps.2004.07.003 · Cited by 6
Apoptosis - the potential pathophysiological mechanism in mood disorders modifiable by lithium salts
Karlović, D. (2008) · Biochemia Medica · doi:10.11613/bm.2008.026 · Cited by 5
Neural Mechanism of Exercise: Neurovascular Responses to Exercise
Yuan, T., Rocha, N., Paes, F., Arias-Carrión, Ó., Machado, S. E. D. C., & Filho, A. S. S. (2015) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527315666151111124543 · Cited by 7
Enhancing resilience to stress: the role of signaling cascades
Yuan, P., Zhou, R., Farzad, N., Gould, T. D., Gray, N. A., Du, J., & Manji, H. K. (2005) · Techniques in the behavioral and neural sciences · doi:10.1016/s0921-0709(05)80040-9 · Cited by 5
Self-citationRat strain differences to fluoxetine in striatal Fos-like proteins
Horowitz, J. M., Hallas, B. H., & Torres, G. (2002) · Neuroreport · doi:10.1097/00001756-200212200-00018 · Cited by 5
Ethological Case Study: Infant Abuse in Rhesus Macaques
Sánchez, M. M., McCormack, K. M., & Maestripieri, D. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511711879.018 · Cited by 6
Depressionen: Eine Störung der Neuroplastizität?
Fuchs, E., & Flügge, G. (2005) · psychoneuro · doi:10.1055/s-2005-870081 · Cited by 9
“durch Monoamine aber auch durch Neuropeptide vermittelt, weisen aktuelle Ergebnisse verschiedenster präklinischer und klinischer Studien darauf hin, dass Störungen der neuroplastischen Prozesse mit verantwortlich sein könnten für depressive Erkrankungen (12) (siehe auch Beitrag von Vollmert und Braus in diesem Heft).”
BackgroundNeurotrophic Factors in Etiology and Treatment of Mood Disorders
Duman, R. S. (2007) · Wiley eBooks · doi:10.1002/9780470101001.hcn019 · Cited by 5
Prenatal Programming of Depression and Schizophrenia?
Dafotakis, M., Vehoff, J., Korr, H., & Schmitz, C. (2002) · Neuroembryology and Aging · doi:10.1159/000063531 · Cited by 5
Pei, Q., Sprakes, M., Millan, M. J., Rochat, C., & Sharp, T. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.05.002 · Cited by 5
Zarrinkalam, E., Arabi, S. M., Komaki, A., & Ranjbar, K. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e17992 · Cited by 5
“(2010) indicated an increase in hippocampal BDNF following six weeks of voluntary aerobic training, and growing evidence indicates the crucial role of the declined brain BDNF levels in the pathogenesis of mood disorders and in the mechanism of action of treatments, including antidepressants and mood stabilizers [46,47…”
BackgroundRominto, A. M., Montarolo, F., Berrino, L., Loddo, M., Bertolotto, A., Tempia, F., & Hoxha, E. (2025) · Scientific Reports · doi:10.1038/s41598-025-22321-7 · Cited by 4
Estrogens and Depression in Women
Rubinow, D. R., Roca, C. A., & Schmidt, P. J. (2007) · Elsevier eBooks · doi:10.1016/b978-012369443-0/50030-2 · Cited by 4
Kumar, B., Jindal, A., Pandey, D. K., Bhatt, S., Devadoss, T., & Mahesh, R. (2012) · PubMed · Cited by 4
Banerjee, R., Hazra, S., Kumar, S., Ghosh, A. K., & Mondal, A. C. (2013) · American Journal of Psychiatry and Neuroscience · doi:10.11648/j.ajpn.20130101.12 · Cited by 4
“Our observation clearly corroborates with the previous findings of the scientists [23-33], and forecasts the rationality of inescapable foot-shocks induced LH model of depression.”
ResultRole of the Endocannabinoid System in the Neurobiology of Suicide
Vinod, K. (2012) · Frontiers in neuroscience · doi:10.1201/b12215-6 · Cited by 10
Özmen, G., Saygın, D. A., Uysal, İ. İ., Özşen, S., Paksoy, Y., & Güler, Ö. (2021) · Anatomy (International Journal of Experimental and Clinical Anatomy) · doi:10.2399/ana.21.1079010 · Cited by 4
“Current studies have related depression with a reduction in the number and/or size of glia and neurons in different brain regions.([23,24]) The role of the cerebellum in regulating emotions has been given more serious consideration over the past three decades.”
BackgroundYe, J., Li, P., Liu, P., Pei, W., Wang, R., Liu, H., Ma, C., & Zhao, D. (2024) · International Journal of COPD · doi:10.2147/copd.s471817 · Cited by 5
“48 On the other hand, retrograde endogenous cannabinoid signaling may also be involved.”
BackgroundDeciphering the role of miRNA-134 in the pathophysiology of depression: A comprehensive review
Wang, Y., Huang, Y., Luo, X., Lai, X., Yu, L., Zhao, Z., Zhang, A., Li, H., Huang, G., Li, Y., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e39026 · Cited by 4
An Overview of Machine Learning Applications in Mood Disorders
Topolski, N., Jeong, S. H., & Mwangi, B. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.017 · Cited by 4
The persisting effects of electroconvulsive stimulation on the hippocampal proteome
O'Donovan, S. M., O’Mara, S. M., Dunn, M. J., & McLoughlin, D. M. (2014) · Brain Research · doi:10.1016/j.brainres.2014.10.020 · Cited by 5
Müller, L. G., Biojone, C., Sales, A. J., Betti, A. H., Herzfeldt, V., Joca, S. R. L., & Rates, S. M. K. (2019) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000534 · Cited by 4
“, 1995; Huang and Reichardt, 2001; Arancio and Chao, 2007) that represents a potential mediator of the plastic changes induced by antidepressants (Manji et al., 2001; Nestler et al., 2002; Duman and Monteggia, 2006).”
BackgroundYang, T., Wang, X., Liu, L., Chen, H., & Wang, N. (2020) · Medical Science Monitor · doi:10.12659/msm.922052 · Cited by 4
“There are reports that impaired neurotransmission caused by downregulation of neurotransmitter production is the main cause of depression [21,22].”
BackgroundRetinoic Acid Signalling in Neuropsychiatric Disease: Possible Markers and Treatment Agents
Bailey, S., & McCaffery, P. J. A. (2009) · Springer eBooks · doi:10.1007/978-1-4020-9838-3_11 · Cited by 4
Gonadal Hormones and Behavior in Women: Concentrations versus Context
Rubinow, D. R., Schmidt, P. J., Meltzer-Brody, S. E., & Harsh, V. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00076-0 · Cited by 5
Expression profile of Bag 1 in the postmortem brain
Curcio, C., Asheld, J. J., Chabla, J. M., Ayubcha, D., Hallas, B. H., Horowitz, J. M., & Torres, G. (2006) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2006.09.003 · Cited by 4
“In this study, the hippocampus was selected for expression analysis of Bag 1 because increasing data suggest that this brain region underlies the pathophysiology of severe mood disorders (Manji et al., 2001).”
MethodPharmacogenetics in psychiatry
Lohoff, F. W. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139025997.007 · Cited by 4
Neurochemical and Transmitter Models of Depression
Anisman, H., Matheson, K., & Hayley, S. P. (2008) · Elsevier eBooks · doi:10.1016/b978-0-08-045078-0.00004-6 · Cited by 7
ANTIDEPRESSANT ACTIVITY OF SPIRULINA PLATENSIS IN EXPERIMENTALLY INDUCED DIPRESSION IN MICE
Suresh, D., Madhu, M., Ch, S., Kumar, R. S., & Shankaraiah, P. (2014) · International Journal of Research and Development in Pharmacy and Life Sciences · Cited by 6
Study on Antidepressant-Like Effects of Radon Inhalation on Forced Swim Induced Depression in Mice
Yamato, K., Kataoka, T., Nishiyama, Y., Takata, Y., Etani, R., & Yamaoka, K. (2016) · RADIOISOTOPES · doi:10.3769/radioisotopes.65.493 · Cited by 4
Hunting for Peripheral Biomarkers to Support Drug Development in Psychiatry
Domenici, E., Muglia, P., & Pich, E. M. (2008) · Springer eBooks · doi:10.1007/978-0-387-79251-4_16 · Cited by 4
Hayley, S. P., Merali, Z., & Anisman, H. (2002) · Acta Neuropsychiatrica · doi:10.1034/j.1601-5215.2002.140606.x · Cited by 5
Fuchs, E., Czéh, B., & Flügge, G. (2005) · Drug Development Research · doi:10.1002/ddr.20032 · Cited by 6
“In the prefrontal and the cingulate cortex, both metabolism and volume of the brain regions are reduced, for example, whereas—with further progression of the syndrome—hippocampal volume loss can also occur [Manji et al., 2001; Manji and Duman, 2001; Sheline et al., 2003].”
The Clinical Neuroscience of Post Stroke Depression
Haroon, E., & Kumar, A. (2004) · Current Neuropharmacology · doi:10.2174/1570159043359567 · Cited by 5
“Neurochemical processes determine the nature and extent of dendritic connections that facilitate recovery from tissue injury [52].”
BackgroundThe inhibition of phosphodiesterase type 5 as a novel target for antidepressant action
Liebenberg, N. (2009) · Cited by 5
Sharma, A., Dhingra, D., Bhutani, R., Nayak, A. K., & Garg, A. (2024) · Current Psychiatry Research and Reviews · doi:10.2174/0126660822261988231127072951 · Cited by 3
Mood Disorders: Brain Imaging and Therapeutic Implications
(2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018 · Cited by 3
Gao, X., Xia, T. C., Mak, S., Zhu, K. Y., Dong, T. T.-X., & Tsim, K. W. K. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/8809546 · Cited by 3
Metadata
- Authors
- Manji, H. K., Drevets, W. C., & Charney, D. S.
- Affiliations
- National Institutes of Health (US)
- National Institute of Mental Health (US)
- Corresponding author
- Manji, Husseini K.
- Venue
- Nature Medicine
- Published
- 2001-05
- Volume
- 7
- Issue
- 5
- Pages
- 541-547
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1509868652
- Cited by
- 1,182
- References
- 66
- Citations by year
- 2026: 7 · 2025: 7 · 2024: 20 · 2023: 21 · 2022: 33 · 2021: 55 · 2020: 29 · 2019: 29 · 2018: 28 · 2017: 30 · 2016: 36 · 2015: 51 · 2014: 50 · 2013: 60 · 2012: 60
- FWCI
- 6.80
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- major depressive disorder, neurobiology of depression, neuroplasticity, cell survival, signaling pathways
- MeSH terms
- Antidepressive Agents, Cell Survival, Depressive Disorder, Glucocorticoids, Neuronal Plasticity, Signal Transduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.